Literature DB >> 808358

Comparative hemodynamic responses to chlorpromazine, nitroprusside, nitroglycerin, and trimethaphan immediately after open-heart operations.

E B Stinson, E L Holloway, G Derby, P E Oyer, J Hollingsworth, R B Griepp, D C Harrison.   

Abstract

The hemodynamic effects of intravenous chlorpormazine, nitroprusside, nitroglycerin, and trimethaphan camsylate were studied in 51 patients with high mean arterial pressures immediately after open-heart operations. Chlorpromazine was given by bolus intravenous injection to 24 patients (average dose 10.3 mg); nitroprusside (17 patients), nitroglycerin (8 patients), and trimethaphan (12 patients) were administered by constant intravenous infusion at average doses of 77 mug/min, 59 mug/min, and .097 mg/min, respectively. Measured or derived variables included right atrial pressure, pulmonary artery pressure, left atrial pressure, systemic arterial pressure, heart rate (HR), cardiac index (CI), stroke index (SI), stroke work index (SWI), and systemic vascular resistance index (SVRI). All four vasodilators significantly reduced systemic and intracardiac pressures and SWI (P less than 0.01). Associated changes in left ventricular pumping performance, however, differed importantly between groups. Chlorpromazine caused a significant rise (+19%) in HR with preservation of SI; thus, CI rose significantly (P less than 0.01). Only nitroprusside, however, resulted in enhancement of SI (P less than 0.05) at the lowered left atrial pressure; CI increased by 19% (P less than 0.01), HR rose minimally (6.5%), and calculated SVRI diminished 33% (P less than 0.01). Both nitroglycerin and trimethaphan caused decreases in SI and CI. These results indicate that in general, among the vasodilators studied, nitroprusside is associated with the most favorable hemodynamic responses in early postoperative cardiac surgical patients.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 808358

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

1.  Abstracts: annual meeting of the Canadian Anesthetists' Society. June 26-29, 1988, Halifax, Nova Scotia.

Authors: 
Journal:  Can J Anaesth       Date:  1988-05       Impact factor: 5.063

Review 2.  Vasodilator therapy in the perioperative period.

Authors:  P N Fyman; J E Cottrell; L Kushins; P A Casthely
Journal:  Can Anaesth Soc J       Date:  1986-09

Review 3.  Intravenous glyceryl trinitrate (nitroglycerin). A review of its pharmacological properties and therapeutic efficacy.

Authors:  E M Sorkin; R N Brogden; J A Romankiewicz
Journal:  Drugs       Date:  1984-01       Impact factor: 9.546

Review 4.  Intravenous vasodilator therapy in congestive heart failure.

Authors:  Kourosh Moazemi; Jatinder S Chana; Anna Marie Willard; Abraham G Kocheril
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

5.  Vasodilator therapy after cardiac surgery: a review of the efficacy and toxicity of nitroglycerin and nitroprusside.

Authors:  J A Kaplan; D C Finlayson; S Woodward
Journal:  Can Anaesth Soc J       Date:  1980-05

Review 6.  Sodium nitroprusside in 2014: A clinical concepts review.

Authors:  Daniel G Hottinger; David S Beebe; Thomas Kozhimannil; Richard C Prielipp; Kumar G Belani
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2014-10

7.  Value of nitroglycerin test in the diagnosis of heart failure in emergency department patients with undifferentiated dyspnea.

Authors:  Adel Sekma; Khaoula Bel Haj Ali; Camilia Jeddi; Nadia Ben Brahim; Nasri Bzeouich; Imen Gannoun; Imen Trabelssi; Kamel Laouiti; Mohamed Habib Grissa; Kaouthar Beltaief; Dridi Zohra; Zorgati Asma; Boukadida Lotfi; Youssef Rym; Houda Ben Soltane; Mezgar Zied; Khrouf Mariem; Mohamed Amine Msolli; Boukef Riadh; Wahid Bouida; Hamdi Boubaker; Semir Nouira
Journal:  Clin Cardiol       Date:  2021-06-02       Impact factor: 2.882

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.